115 related articles for article (PubMed ID: 29902567)
1. Pre- and post-surgery MRSI predictive value in adult oligodendroglioma prognosis.
Bund C; Lefebvre F; Schott R; Chenard MP; Lhermitte B; Cebula H; Kremer S; Proust F; Namer IJ
Magn Reson Imaging; 2018 Oct; 52():75-83. PubMed ID: 29902567
[TBL] [Abstract][Full Text] [Related]
2. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
[TBL] [Abstract][Full Text] [Related]
3. Correlations between magnetic resonance spectroscopy and image-guided histopathology, with special attention to radiation necrosis.
Rock JP; Hearshen D; Scarpace L; Croteau D; Gutierrez J; Fisher JL; Rosenblum ML; Mikkelsen T
Neurosurgery; 2002 Oct; 51(4):912-9; discussion 919-20. PubMed ID: 12234397
[TBL] [Abstract][Full Text] [Related]
4. Role of proton magnetic resonance spectroscopy in differentiating oligodendrogliomas from astrocytomas.
Chawla S; Oleaga L; Wang S; Krejza J; Wolf RL; Woo JH; O'Rourke DM; Judy KD; Grady MS; Melhem ER; Poptani H
J Neuroimaging; 2010 Jan; 20(1):3-8. PubMed ID: 19021846
[TBL] [Abstract][Full Text] [Related]
5. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
6. ACRIN 6684: Multicenter, phase II assessment of tumor hypoxia in newly diagnosed glioblastoma using magnetic resonance spectroscopy.
Ratai EM; Zhang Z; Fink J; Muzi M; Hanna L; Greco E; Richards T; Kim D; Andronesi OC; Mintz A; Kostakoglu L; Prah M; Ellingson B; Schmainda K; Sorensen G; Barboriak D; Mankoff D; Gerstner ER;
PLoS One; 2018; 13(6):e0198548. PubMed ID: 29902200
[TBL] [Abstract][Full Text] [Related]
7. Comparison of magnetic resonance spectroscopy and perfusion-weighted imaging in presurgical grading of oligodendroglial tumors.
Xu M; See SJ; Ng WH; Arul E; Back MF; Yeo TT; Lim CC
Neurosurgery; 2005 May; 56(5):919-26; discussion 919-26. PubMed ID: 15854239
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between intra-axial metastatic tumor progression and radiation injury following fractionated radiation therapy or stereotactic radiosurgery using MR spectroscopy, perfusion MR imaging or volume progression modeling.
Huang J; Wang AM; Shetty A; Maitz AH; Yan D; Doyle D; Richey K; Park S; Pieper DR; Chen PY; Grills IS
Magn Reson Imaging; 2011 Sep; 29(7):993-1001. PubMed ID: 21571478
[TBL] [Abstract][Full Text] [Related]
9. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
10. Proton magnetic resonance spectroscopic imaging of cerebral gliomas: correlation of metabolite ratios with histopathologic grading.
Hsu YY; Chang CN; Wie KJ; Lim KE; Hsu WC; Jung SM
Chang Gung Med J; 2004 Jun; 27(6):399-407. PubMed ID: 15455540
[TBL] [Abstract][Full Text] [Related]
11. Role of MRSI Major Metabolite Ratios in Differentiating Between Intracerebral Ring-Enhancing Neoplastic and Non-Neoplastic Lesions, High-Grade Gliomas and Metastases, and High-Grade and Low-Grade Gliomas.
Ankush A; Sardessai S
Cureus; 2022 Nov; 14(11):e31841. PubMed ID: 36579207
[TBL] [Abstract][Full Text] [Related]
12. Multimodal MRI in the characterization of glial neoplasms: the combined role of single-voxel MR spectroscopy, diffusion imaging and echo-planar perfusion imaging.
Zonari P; Baraldi P; Crisi G
Neuroradiology; 2007 Oct; 49(10):795-803. PubMed ID: 17619871
[TBL] [Abstract][Full Text] [Related]
13. Dynamic Contrast-Enhanced MRI in Low-Grade Versus Anaplastic Oligodendrogliomas.
Arevalo-Perez J; Kebede AA; Peck KK; Diamond E; Holodny AI; Rosenblum M; Rubel J; Gaal J; Hatzoglou V
J Neuroimaging; 2016 May; 26(3):366-71. PubMed ID: 26707628
[TBL] [Abstract][Full Text] [Related]
14. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
[TBL] [Abstract][Full Text] [Related]
15. In vivo assessment of prostate cancer aggressiveness using magnetic resonance spectroscopic imaging at 3 T with an endorectal coil.
Kobus T; Hambrock T; Hulsbergen-van de Kaa CA; Wright AJ; Barentsz JO; Heerschap A; Scheenen TW
Eur Urol; 2011 Nov; 60(5):1074-80. PubMed ID: 21419565
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
[TBL] [Abstract][Full Text] [Related]
17. Image-fusion of MR spectroscopic images for treatment planning of gliomas.
Chang J; Thakur S; Perera G; Kowalski A; Huang W; Karimi S; Hunt M; Koutcher J; Fuks Z; Amols H; Narayana A
Med Phys; 2006 Jan; 33(1):32-40. PubMed ID: 16485406
[TBL] [Abstract][Full Text] [Related]
18. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
19. Proton MR spectroscopy of cerebral gliomas at 3 T: spatial heterogeneity, and tumour grade and extent.
Di Costanzo A; Scarabino T; Trojsi F; Popolizio T; Catapano D; Giannatempo GM; Bonavita S; Portaluri M; Tosetti M; d'Angelo VA; Salvolini U; Tedeschi G
Eur Radiol; 2008 Aug; 18(8):1727-35. PubMed ID: 18389246
[TBL] [Abstract][Full Text] [Related]
20. Proton magnetic resonance spectroscopic imaging can predict length of survival in patients with supratentorial gliomas.
Kuznetsov YE; Caramanos Z; Antel SB; Preul MC; Leblanc R; Villemure JG; Pokrupa R; Olivier A; Sadikot A; Arnold DL
Neurosurgery; 2003 Sep; 53(3):565-74; discussion 574-6. PubMed ID: 12943573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
